INMED PHARMACEUTICALS INC (INM)

CA4576376012 - Common Stock

0.301  +0 (+0.33%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
Revenue
5.48M4.14M1.09M0.000.00
Cost Of Goods
3.38M2.73M550.00KN/AN/A
Gross Profit
2.10M1.40M540.00KN/AN/A
Operating Expenses
9.10M9.78M14.13M9.94M9.15M
Research and Development
3.40M3.73M7.28M5.34M5.81M
Selling, General, and Administrative Expenses
5.48M5.85M6.67M4.48M3.16M
Operating Income
-6.99M-8.38M-13.59M-9.94M-9.15M
Interest Income/Expense
646.66K440.00K-20.00K100.00K210.00K
Other Income/Expense
N/AN/A-1.31M-360.00K0.00
Non Recurring Items
N/AN/A-3.67MN/AN/A
Income Before Taxes
-6.36M-7.93M-18.60M-10.20M-8.94M
Income Tax
0.0010.00KN/AN/AN/A
Net Income
-6.36M-7.95M-18.60M-10.20M-8.94M
EBITDA
-6.78M-8.18M-13.40M-9.82M-9.04M
 
Per Share Data
EPS Diluted Total Ops
-1.65-3.25-33.21-37.77-42.57
Non GAAP EPS
N/AN/A-34.28N/AN/A
 
Statistics
Gross Profit Margin
38.40%33.82%49.54%N/AN/A
Profit Margin
-116.02%-192.03%-1706.42%N/AN/A
Operating Profit Margin
-127.64%-202.42%-1246.79%N/AN/A

All data in USD

Charts